Geoffrey Kenneth Cooper

Title: Geoffrey Kenneth Cooper: Innovator in Proton Pump Inhibitors

Introduction

Geoffrey Kenneth Cooper is a notable inventor based in Scappoose, Oregon. He has made significant contributions to the field of pharmaceuticals, particularly in the development of proton pump inhibitors. His innovative work has led to the creation of a patent that enhances the efficacy of these important medications.

Latest Patents

Geoffrey Kenneth Cooper holds a patent for a "Process for preparing isomerically pure prodrugs of proton pump inhibitors." This patent details synthetic methods for preparing isomerically pure N-arylsulfonyl derivatives of proton pump inhibitors, which include a substituted benzimidazole nucleus. The patent showcases various synthetic schemes and experimental descriptions that underline the importance of his work in this area.

Career Highlights

Cooper is associated with Allergan, Inc., a leading company in the pharmaceutical industry. His role at Allergan has allowed him to focus on innovative drug development, contributing to advancements in therapeutic options for patients. His expertise in synthetic chemistry has been instrumental in the progress of proton pump inhibitors.

Collaborations

Throughout his career, Geoffrey Kenneth Cooper has collaborated with esteemed colleagues, including Michael E. Garst and Lloyd Jay Dolby. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their field.

Conclusion

Geoffrey Kenneth Cooper's contributions to the development of proton pump inhibitors exemplify the impact of innovation in pharmaceuticals. His patent and work at Allergan, Inc. highlight his commitment to improving patient care through scientific advancements.